Gelesis Holdings, Inc.
GLSHDelisted Apr 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805087
Gelesis Holdings, Inc. was delisted on Apr 26, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 39 institutions reported holding it in 13F filings for Q1 2023, worth $3.55M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Gelesis Holdings, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 38 | +1 |
| Shares | 9.69M | 4.70K | 12.2M | +2.52M (+26.0%) |
| Value | $15.0M | $7.00K | $13.2M | −$1.80M (−12.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Gelesis Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vitruvian Partners LLP | 1,876,106 | $2.03M | 0.36% |
| Allspring Global Investments Holdings, LLC | 25,957 | $28.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 5,889 | $6.36K | 0.00% |
| FMR LLC | 1,236 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Gelesis Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Squarepoint Ops LLC | 27,650 | $43.0K |
| Penserra Capital Management LLC | 3,865 | $5.00K |
| Ameritas Investment Partners, Inc. | 739 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Gelesis Holdings, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brewin Dolphin Ltd | 4,700 | $7.00K |